Leadership & Pay ·
On June 10, 2026, Palisade Bio, Inc. appointed Jordan Zwick to its Board of Directors and Audit Committee, expanding…
PALIPalisade Bio, Inc.
On June 10, 2026, Palisade Bio, Inc. appointed Jordan Zwick to its Board of Directors and Audit Committee, expanding the Board to six members. Mr. Zwick received an initial restricted stock unit grant valued at $566,000 vesting over three years. At its annual meeting, stockholders approved increasing the number of authorized shares of common stock from 300,000,000 to 450,000,000. Stockholders also approved the Amended and Restated 2021 Equity Incentive Plan and the Amended and Restated 2021 Employee Stock Purchase Plan. The company operates in the biotechnology industry and develops therapeutic products.